UK markets closed

OrthoPediatrics Corp. (KIDS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
28.76-0.03 (-0.10%)
At close: 04:00PM EDT
28.76 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close28.79
Open29.98
Bid28.71 x 400
Ask28.98 x 300
Day's range28.08 - 30.27
52-week range23.10 - 45.96
Volume692,405
Avg. volume150,387
Market cap685.319M
Beta (5Y monthly)1.18
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference

    WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer is scheduled to participate in a fireside chat at the Truist Securities MedTech Conference, being held in Boston, MA. Event:Truist Securities MedTech ConferenceFormat:Fireside ChatDate:Tuesday, June 18, 2024Time:4:45 pm ET An aud

  • GlobeNewswire

    OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting

    Reinforced Long-Term Commitment as Emerald SponsorWARSAW, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the combined 2024 Pediatric Orthopaedic Society of North America (“POSNA”) and European Paediatric Orthopaedic Society (“EPOS”) annual meeting as an Emerald sponsor. At the Annual Meeting, the Company highlighted its growing

  • GlobeNewswire

    OrthoPediatrics Corp. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance

    First Quarter 2024 Revenue Increased 41% Year-over-YearWARSAW, Ind., May 06, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2024. First Quarter 2024 and Business Highlights Helped nearly 28,000 children in the first quarter of 2024, an increase of 47% from the first quarter 2023Generated tot